Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 251 | 2012 | 6939 | 5.790 |
Why?
|
Acquired Immunodeficiency Syndrome | 153 | 2014 | 2232 | 5.440 |
Why?
|
Antibodies, Viral | 91 | 2024 | 3176 | 3.600 |
Why?
|
HIV Envelope Protein gp120 | 72 | 2007 | 952 | 3.220 |
Why?
|
Adenoviridae | 39 | 2012 | 1099 | 2.850 |
Why?
|
HIV Antibodies | 85 | 2014 | 1322 | 2.670 |
Why?
|
Influenza A Virus, H5N1 Subtype | 13 | 2024 | 113 | 2.480 |
Why?
|
HIV Antigens | 61 | 1998 | 347 | 2.460 |
Why?
|
RNA, Viral | 78 | 2010 | 2902 | 2.370 |
Why?
|
HIV Seropositivity | 70 | 2007 | 971 | 2.360 |
Why?
|
HIV Infections | 155 | 2012 | 16718 | 2.110 |
Why?
|
Zidovudine | 42 | 2005 | 620 | 2.080 |
Why?
|
Genetic Vectors | 50 | 2012 | 3420 | 1.820 |
Why?
|
Influenza Vaccines | 18 | 2024 | 738 | 1.820 |
Why?
|
HIV | 43 | 2014 | 1604 | 1.770 |
Why?
|
Epitopes | 48 | 2024 | 2571 | 1.720 |
Why?
|
Sarcoma, Kaposi | 22 | 2005 | 370 | 1.720 |
Why?
|
Antigens, Viral | 35 | 2011 | 1035 | 1.710 |
Why?
|
Viral Envelope Proteins | 29 | 2011 | 635 | 1.650 |
Why?
|
Neutralization Tests | 51 | 2017 | 758 | 1.650 |
Why?
|
Adenoviruses, Human | 22 | 2012 | 257 | 1.570 |
Why?
|
Phylogeny | 57 | 2021 | 2803 | 1.560 |
Why?
|
Herpesvirus 8, Human | 15 | 2005 | 258 | 1.550 |
Why?
|
Rabies virus | 7 | 2012 | 39 | 1.490 |
Why?
|
Molecular Sequence Data | 136 | 2018 | 18111 | 1.460 |
Why?
|
Antibodies, Monoclonal | 40 | 2024 | 9274 | 1.460 |
Why?
|
Orthomyxoviridae Infections | 12 | 2017 | 248 | 1.460 |
Why?
|
Substance Abuse, Intravenous | 26 | 2007 | 525 | 1.460 |
Why?
|
Malaria Vaccines | 11 | 2011 | 158 | 1.330 |
Why?
|
Reverse Transcriptase Inhibitors | 18 | 2004 | 615 | 1.310 |
Why?
|
Antibodies, Neutralizing | 18 | 2024 | 1978 | 1.290 |
Why?
|
Virus Replication | 52 | 2021 | 2534 | 1.280 |
Why?
|
Peptide Fragments | 48 | 2004 | 5097 | 1.230 |
Why?
|
Gene Products, gag | 31 | 2012 | 337 | 1.230 |
Why?
|
Viral Vaccines | 20 | 2012 | 636 | 1.190 |
Why?
|
Amino Acid Sequence | 103 | 2017 | 13815 | 1.190 |
Why?
|
Genes, env | 16 | 2009 | 95 | 1.160 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 11 | 2024 | 157 | 1.140 |
Why?
|
Influenza, Human | 12 | 2024 | 1479 | 1.140 |
Why?
|
Homosexuality | 50 | 2000 | 262 | 1.140 |
Why?
|
HIV Reverse Transcriptase | 10 | 2001 | 213 | 1.090 |
Why?
|
DNA, Viral | 47 | 2009 | 2225 | 1.030 |
Why?
|
AIDS Vaccines | 16 | 2012 | 938 | 1.000 |
Why?
|
Rabies | 5 | 2008 | 61 | 0.990 |
Why?
|
Netherlands | 58 | 2021 | 2170 | 0.960 |
Why?
|
Vaccines, Synthetic | 22 | 2012 | 634 | 0.920 |
Why?
|
Influenza A Virus, H1N1 Subtype | 10 | 2019 | 459 | 0.910 |
Why?
|
HIV Core Protein p24 | 34 | 2001 | 256 | 0.880 |
Why?
|
tau Proteins | 5 | 2020 | 1868 | 0.870 |
Why?
|
Viral Core Proteins | 21 | 2003 | 162 | 0.820 |
Why?
|
Evolution, Molecular | 18 | 2002 | 1940 | 0.820 |
Why?
|
Base Sequence | 67 | 2007 | 12797 | 0.810 |
Why?
|
Immunoglobulin G | 34 | 2021 | 4560 | 0.800 |
Why?
|
Antigenic Variation | 11 | 2006 | 125 | 0.790 |
Why?
|
Deltaretrovirus | 15 | 1990 | 170 | 0.790 |
Why?
|
Immunization, Secondary | 15 | 2012 | 340 | 0.790 |
Why?
|
Genes, gag | 13 | 2004 | 61 | 0.750 |
Why?
|
Adenoviridae Infections | 4 | 2011 | 96 | 0.750 |
Why?
|
Anti-HIV Agents | 30 | 2006 | 4256 | 0.740 |
Why?
|
Genes, Viral | 19 | 2010 | 718 | 0.730 |
Why?
|
Immunologic Memory | 11 | 2017 | 1348 | 0.730 |
Why?
|
Antibody Specificity | 22 | 2018 | 1095 | 0.730 |
Why?
|
Aging | 7 | 2024 | 8664 | 0.730 |
Why?
|
B-Lymphocytes | 21 | 2019 | 4665 | 0.720 |
Why?
|
Biological Evolution | 10 | 2004 | 1076 | 0.720 |
Why?
|
Viral Proteins | 19 | 2010 | 1900 | 0.720 |
Why?
|
Influenza A virus | 7 | 2015 | 456 | 0.710 |
Why?
|
Gene Products, env | 14 | 2012 | 263 | 0.700 |
Why?
|
Serologic Tests | 3 | 2020 | 374 | 0.700 |
Why?
|
Protozoan Proteins | 8 | 2011 | 827 | 0.690 |
Why?
|
Retroviridae Proteins | 12 | 1990 | 98 | 0.680 |
Why?
|
CD4 Lymphocyte Count | 33 | 2010 | 2559 | 0.670 |
Why?
|
Hepacivirus | 9 | 2002 | 1379 | 0.670 |
Why?
|
Vaccines | 3 | 2023 | 822 | 0.670 |
Why?
|
Herpesviridae Infections | 6 | 2002 | 277 | 0.670 |
Why?
|
Immunoglobulin Light Chains | 2 | 2018 | 277 | 0.660 |
Why?
|
Tuberculosis Vaccines | 6 | 2012 | 50 | 0.660 |
Why?
|
Simian immunodeficiency virus | 13 | 2012 | 846 | 0.640 |
Why?
|
RNA, Ribosomal | 5 | 2002 | 246 | 0.630 |
Why?
|
CD4-Positive T-Lymphocytes | 42 | 2012 | 4386 | 0.620 |
Why?
|
Dementia | 12 | 2021 | 2518 | 0.610 |
Why?
|
Humans | 496 | 2024 | 744343 | 0.610 |
Why?
|
Plasmodium falciparum | 9 | 2011 | 1732 | 0.600 |
Why?
|
T-Lymphocytes | 37 | 2015 | 10180 | 0.600 |
Why?
|
Mice, Inbred BALB C | 28 | 2024 | 6386 | 0.600 |
Why?
|
Antibodies, Protozoan | 8 | 2011 | 253 | 0.590 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2018 | 659 | 0.580 |
Why?
|
Genetic Variation | 29 | 2007 | 6544 | 0.570 |
Why?
|
Epitopes, T-Lymphocyte | 7 | 2008 | 880 | 0.570 |
Why?
|
Severe Acute Respiratory Syndrome | 3 | 2006 | 137 | 0.570 |
Why?
|
AIDS Dementia Complex | 7 | 2001 | 154 | 0.560 |
Why?
|
West Nile Fever | 6 | 2010 | 81 | 0.560 |
Why?
|
SAIDS Vaccines | 4 | 2012 | 166 | 0.550 |
Why?
|
Recombination, Genetic | 12 | 2010 | 1586 | 0.540 |
Why?
|
Cross Reactions | 17 | 2021 | 841 | 0.530 |
Why?
|
Leukocytes, Mononuclear | 25 | 2012 | 1836 | 0.530 |
Why?
|
Viral Load | 32 | 2021 | 3299 | 0.530 |
Why?
|
Papio | 8 | 2000 | 656 | 0.520 |
Why?
|
Cell Line | 51 | 2018 | 15997 | 0.520 |
Why?
|
Animals | 149 | 2024 | 168757 | 0.510 |
Why?
|
Cerebrovascular Disorders | 1 | 2022 | 1504 | 0.510 |
Why?
|
Adjuvants, Immunologic | 7 | 2015 | 1000 | 0.500 |
Why?
|
Vaccines, Virosome | 4 | 2015 | 5 | 0.500 |
Why?
|
Neurofibrillary Tangles | 1 | 2017 | 439 | 0.500 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 6 | 2009 | 570 | 0.490 |
Why?
|
Hepatitis C Antibodies | 6 | 2000 | 145 | 0.490 |
Why?
|
Polymerase Chain Reaction | 41 | 2006 | 6171 | 0.490 |
Why?
|
Retroviridae | 6 | 2000 | 914 | 0.490 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 35 | 2013 | 3870 | 0.490 |
Why?
|
HIV Protease | 4 | 2001 | 96 | 0.480 |
Why?
|
Homosexuality, Male | 21 | 2003 | 1240 | 0.480 |
Why?
|
Antigens, Protozoan | 4 | 2011 | 322 | 0.470 |
Why?
|
West Nile Virus Vaccines | 3 | 2007 | 4 | 0.470 |
Why?
|
Pan troglodytes | 16 | 1998 | 229 | 0.470 |
Why?
|
Cercopithecidae | 3 | 2000 | 22 | 0.470 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.470 |
Why?
|
Self-Sustained Sequence Replication | 10 | 2005 | 15 | 0.460 |
Why?
|
Astroviridae | 2 | 2004 | 4 | 0.460 |
Why?
|
West Nile virus | 6 | 2010 | 82 | 0.460 |
Why?
|
Parvovirus | 2 | 2004 | 4 | 0.440 |
Why?
|
HIV Envelope Protein gp41 | 8 | 1994 | 314 | 0.440 |
Why?
|
Hepatitis C | 7 | 2000 | 1591 | 0.440 |
Why?
|
Disease Outbreaks | 9 | 2007 | 1772 | 0.440 |
Why?
|
Sequence Homology, Nucleic Acid | 10 | 2002 | 1085 | 0.430 |
Why?
|
Vaccination | 16 | 2023 | 3278 | 0.430 |
Why?
|
Macaca mulatta | 18 | 2012 | 2375 | 0.430 |
Why?
|
Hepatitis C Antigens | 4 | 1999 | 34 | 0.430 |
Why?
|
Proviruses | 9 | 2001 | 318 | 0.410 |
Why?
|
Binding Sites, Antibody | 7 | 2011 | 349 | 0.410 |
Why?
|
Immunodominant Epitopes | 7 | 2018 | 267 | 0.410 |
Why?
|
Plaque, Amyloid | 1 | 2016 | 729 | 0.410 |
Why?
|
Alzheimer Disease | 13 | 2020 | 8037 | 0.410 |
Why?
|
Capsid Proteins | 9 | 2009 | 479 | 0.390 |
Why?
|
HIV Long Terminal Repeat | 8 | 2003 | 88 | 0.390 |
Why?
|
Interferon-gamma | 13 | 2011 | 3206 | 0.390 |
Why?
|
Antiviral Agents | 9 | 2017 | 2987 | 0.390 |
Why?
|
Male | 229 | 2021 | 350118 | 0.390 |
Why?
|
CD8-Positive T-Lymphocytes | 21 | 2012 | 4479 | 0.390 |
Why?
|
AIDS-Related Opportunistic Infections | 7 | 2005 | 657 | 0.390 |
Why?
|
Ebola Vaccines | 4 | 2012 | 24 | 0.370 |
Why?
|
Sequence Alignment | 19 | 2009 | 2256 | 0.370 |
Why?
|
Vaccines, Inactivated | 2 | 2007 | 184 | 0.370 |
Why?
|
Retroviridae Infections | 5 | 1996 | 151 | 0.360 |
Why?
|
Antibody Formation | 16 | 2007 | 1402 | 0.360 |
Why?
|
Amyloid beta-Peptides | 3 | 2020 | 3587 | 0.360 |
Why?
|
Consensus Sequence | 9 | 2001 | 377 | 0.350 |
Why?
|
Genome, Viral | 9 | 2005 | 667 | 0.350 |
Why?
|
Immunoglobulins | 3 | 2012 | 881 | 0.350 |
Why?
|
Longevity | 3 | 2024 | 1070 | 0.350 |
Why?
|
Oseltamivir | 1 | 2009 | 75 | 0.350 |
Why?
|
Hemophilia A | 11 | 1993 | 351 | 0.350 |
Why?
|
Giant Cells | 10 | 1999 | 187 | 0.340 |
Why?
|
Antibodies | 8 | 2019 | 2460 | 0.340 |
Why?
|
Antiretroviral Therapy, Highly Active | 6 | 2006 | 1873 | 0.340 |
Why?
|
Immunization, Passive | 4 | 2008 | 623 | 0.340 |
Why?
|
Immunity, Humoral | 4 | 2021 | 598 | 0.340 |
Why?
|
Dendritic Cells | 15 | 2011 | 2725 | 0.340 |
Why?
|
Genes, pol | 7 | 2001 | 51 | 0.330 |
Why?
|
Drug Resistance, Microbial | 15 | 2001 | 862 | 0.330 |
Why?
|
Influenza A Virus, H9N2 Subtype | 1 | 2008 | 8 | 0.330 |
Why?
|
Genetic Enhancement | 1 | 2008 | 18 | 0.330 |
Why?
|
AIDS-Related Complex | 10 | 1995 | 110 | 0.330 |
Why?
|
Mice | 60 | 2024 | 81183 | 0.320 |
Why?
|
DNA Primers | 19 | 2007 | 2892 | 0.320 |
Why?
|
Haplorhini | 3 | 2000 | 552 | 0.320 |
Why?
|
Cercopithecinae | 2 | 2000 | 3 | 0.320 |
Why?
|
Immunity, Cellular | 13 | 2015 | 1607 | 0.320 |
Why?
|
Adenovirus E1 Proteins | 2 | 2006 | 6 | 0.320 |
Why?
|
Molecular Epidemiology | 6 | 2006 | 468 | 0.320 |
Why?
|
Immunoglobulin M | 5 | 2008 | 1537 | 0.310 |
Why?
|
Sequence Homology, Amino Acid | 16 | 2009 | 2839 | 0.310 |
Why?
|
Geese | 1 | 2007 | 19 | 0.310 |
Why?
|
DNA, Mitochondrial | 5 | 2004 | 817 | 0.310 |
Why?
|
Poultry Diseases | 1 | 2007 | 25 | 0.310 |
Why?
|
Influenza in Birds | 1 | 2008 | 75 | 0.310 |
Why?
|
Prion Diseases | 1 | 2009 | 88 | 0.310 |
Why?
|
Prions | 2 | 2009 | 180 | 0.310 |
Why?
|
Epitope Mapping | 7 | 2009 | 311 | 0.300 |
Why?
|
Administration, Intranasal | 3 | 2024 | 446 | 0.300 |
Why?
|
Viral Nonstructural Proteins | 3 | 1999 | 241 | 0.300 |
Why?
|
Transfection | 15 | 2009 | 5892 | 0.300 |
Why?
|
Influenza A Virus, H3N2 Subtype | 4 | 2014 | 90 | 0.300 |
Why?
|
Membrane Glycoproteins | 6 | 2008 | 3768 | 0.290 |
Why?
|
Serotyping | 13 | 2007 | 338 | 0.290 |
Why?
|
Cell Fusion | 10 | 1992 | 297 | 0.290 |
Why?
|
Nucleocapsid Proteins | 3 | 2005 | 77 | 0.290 |
Why?
|
Virus Internalization | 4 | 2019 | 501 | 0.280 |
Why?
|
Protein Engineering | 2 | 2021 | 540 | 0.280 |
Why?
|
Immune Sera | 6 | 2008 | 641 | 0.280 |
Why?
|
RNA-Directed DNA Polymerase | 6 | 1995 | 248 | 0.280 |
Why?
|
Adult | 125 | 2021 | 214055 | 0.280 |
Why?
|
Cohort Studies | 47 | 2021 | 40561 | 0.270 |
Why?
|
Th1 Cells | 2 | 2010 | 1057 | 0.270 |
Why?
|
Recombinant Proteins | 14 | 2009 | 6622 | 0.270 |
Why?
|
Receptors, CCR5 | 8 | 2004 | 497 | 0.270 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 738 | 0.260 |
Why?
|
Rabies Vaccines | 3 | 2012 | 31 | 0.260 |
Why?
|
Hemorrhagic Fever, Ebola | 4 | 2012 | 428 | 0.250 |
Why?
|
Endogenous Retroviruses | 3 | 2001 | 112 | 0.250 |
Why?
|
Immunoenzyme Techniques | 12 | 2006 | 1799 | 0.250 |
Why?
|
Amino Acids | 5 | 2001 | 1736 | 0.250 |
Why?
|
Female | 122 | 2021 | 380194 | 0.250 |
Why?
|
Immunization Schedule | 5 | 2015 | 221 | 0.250 |
Why?
|
Vaccines, DNA | 6 | 2010 | 305 | 0.250 |
Why?
|
Immunization | 10 | 2015 | 1256 | 0.250 |
Why?
|
Viral Regulatory and Accessory Proteins | 3 | 1996 | 159 | 0.240 |
Why?
|
HIV-2 | 6 | 1993 | 167 | 0.240 |
Why?
|
Time Factors | 51 | 2016 | 40075 | 0.240 |
Why?
|
Binding Sites | 10 | 2017 | 6114 | 0.240 |
Why?
|
Stavudine | 2 | 2001 | 85 | 0.240 |
Why?
|
Phenotype | 28 | 2021 | 16365 | 0.240 |
Why?
|
Transduction, Genetic | 7 | 2009 | 913 | 0.230 |
Why?
|
Lymphokines | 2 | 2002 | 949 | 0.230 |
Why?
|
Influenza B virus | 3 | 2012 | 50 | 0.230 |
Why?
|
Biological Assay | 1 | 2006 | 652 | 0.230 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2005 | 1821 | 0.220 |
Why?
|
Cricetinae | 8 | 2021 | 2472 | 0.220 |
Why?
|
Sequence Analysis, DNA | 16 | 2009 | 4803 | 0.220 |
Why?
|
Genes, nef | 2 | 1992 | 55 | 0.210 |
Why?
|
Turtles | 1 | 2002 | 40 | 0.210 |
Why?
|
Mass Vaccination | 1 | 2003 | 105 | 0.210 |
Why?
|
Antibody Affinity | 3 | 2009 | 254 | 0.210 |
Why?
|
Creutzfeldt-Jakob Syndrome | 6 | 1986 | 89 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Cats | 2 | 2002 | 998 | 0.210 |
Why?
|
Genotype | 24 | 2010 | 12951 | 0.200 |
Why?
|
Mutation | 24 | 2019 | 29786 | 0.200 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2006 | 1572 | 0.200 |
Why?
|
Dose-Response Relationship, Immunologic | 6 | 2012 | 370 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.200 |
Why?
|
Ethiopia | 14 | 2010 | 495 | 0.200 |
Why?
|
Glycoproteins | 5 | 2005 | 2263 | 0.200 |
Why?
|
Species Specificity | 11 | 2013 | 2478 | 0.200 |
Why?
|
o-Phthalaldehyde | 1 | 2001 | 16 | 0.200 |
Why?
|
T-Lymphocytes, Helper-Inducer | 6 | 2012 | 986 | 0.200 |
Why?
|
Mesocricetus | 5 | 2021 | 252 | 0.200 |
Why?
|
Parvoviridae Infections | 1 | 2001 | 35 | 0.200 |
Why?
|
Viremia | 8 | 2005 | 736 | 0.190 |
Why?
|
Hepatitis B | 4 | 2001 | 695 | 0.190 |
Why?
|
Heterosexuality | 4 | 2001 | 276 | 0.190 |
Why?
|
Peptide Library | 3 | 2008 | 349 | 0.190 |
Why?
|
Immunoglobulin Variable Region | 4 | 2006 | 421 | 0.190 |
Why?
|
Medically Underserved Area | 1 | 2003 | 253 | 0.190 |
Why?
|
Recombinant Fusion Proteins | 10 | 2009 | 3772 | 0.190 |
Why?
|
International Cooperation | 3 | 2001 | 1420 | 0.190 |
Why?
|
Retina | 2 | 2008 | 2616 | 0.180 |
Why?
|
Human T-lymphotropic virus 1 | 4 | 1994 | 140 | 0.180 |
Why?
|
Drug Resistance, Multiple | 1 | 2001 | 252 | 0.180 |
Why?
|
Classification | 1 | 2000 | 129 | 0.180 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2014 | 482 | 0.180 |
Why?
|
Repetitive Sequences, Nucleic Acid | 8 | 1997 | 798 | 0.180 |
Why?
|
Models, Molecular | 6 | 2018 | 5456 | 0.180 |
Why?
|
Viral Fusion Proteins | 2 | 1992 | 95 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.180 |
Why?
|
Kinetics | 12 | 2014 | 6473 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 694 | 0.180 |
Why?
|
Gene Deletion | 2 | 2006 | 2751 | 0.170 |
Why?
|
Thymidine | 3 | 1988 | 310 | 0.170 |
Why?
|
Birds | 3 | 2008 | 163 | 0.170 |
Why?
|
Stroke | 1 | 2022 | 9981 | 0.170 |
Why?
|
beta 2-Microglobulin | 5 | 1992 | 315 | 0.170 |
Why?
|
Lymphocyte Activation | 14 | 2010 | 5524 | 0.170 |
Why?
|
Vaccines, Subunit | 2 | 2010 | 168 | 0.170 |
Why?
|
Spleen | 7 | 2011 | 2362 | 0.170 |
Why?
|
Virion | 4 | 2014 | 433 | 0.170 |
Why?
|
Hemagglutination Inhibition Tests | 4 | 2015 | 77 | 0.170 |
Why?
|
Immunocompetence | 2 | 1998 | 137 | 0.170 |
Why?
|
Factor X | 2 | 2009 | 64 | 0.170 |
Why?
|
Models, Statistical | 2 | 2006 | 5102 | 0.170 |
Why?
|
Gene Products, pol | 4 | 2003 | 47 | 0.170 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1366 | 0.170 |
Why?
|
Crystallization | 2 | 2018 | 524 | 0.170 |
Why?
|
Brain Diseases | 8 | 1989 | 1563 | 0.170 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.170 |
Why?
|
Virus Diseases | 3 | 1999 | 711 | 0.170 |
Why?
|
Gene Products, vpr | 2 | 1996 | 36 | 0.160 |
Why?
|
Lewy Bodies | 1 | 2019 | 137 | 0.160 |
Why?
|
Infection Control | 1 | 2006 | 966 | 0.160 |
Why?
|
Adaptation, Biological | 2 | 1998 | 153 | 0.160 |
Why?
|
Sexual Behavior | 15 | 2002 | 2057 | 0.160 |
Why?
|
Models, Biological | 6 | 2003 | 9583 | 0.160 |
Why?
|
Open Reading Frames | 3 | 2002 | 810 | 0.160 |
Why?
|
Conserved Sequence | 6 | 2012 | 1202 | 0.160 |
Why?
|
Seroepidemiologic Studies | 6 | 2007 | 401 | 0.160 |
Why?
|
Lamivudine | 8 | 2005 | 342 | 0.160 |
Why?
|
Reassortant Viruses | 3 | 2009 | 37 | 0.160 |
Why?
|
Disease Progression | 21 | 2017 | 13284 | 0.160 |
Why?
|
Milk, Human | 2 | 2007 | 490 | 0.160 |
Why?
|
Program Development | 2 | 2021 | 1316 | 0.160 |
Why?
|
Patient Admission | 1 | 2006 | 1380 | 0.160 |
Why?
|
Cross Protection | 2 | 2015 | 24 | 0.160 |
Why?
|
Influenza A Virus, H2N2 Subtype | 1 | 2017 | 3 | 0.160 |
Why?
|
Malaria, Falciparum | 5 | 2011 | 1077 | 0.160 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2015 | 40 | 0.160 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2018 | 87 | 0.160 |
Why?
|
Aluminum Compounds | 2 | 2008 | 51 | 0.160 |
Why?
|
Neurofilament Proteins | 1 | 2020 | 318 | 0.160 |
Why?
|
Founder Effect | 1 | 1998 | 189 | 0.160 |
Why?
|
Tuberculosis | 2 | 2009 | 1912 | 0.160 |
Why?
|
Crystallography, X-Ray | 5 | 2018 | 2011 | 0.160 |
Why?
|
Carrier State | 1 | 2001 | 518 | 0.160 |
Why?
|
HIV Long-Term Survivors | 1 | 1998 | 126 | 0.160 |
Why?
|
Acyltransferases | 2 | 2012 | 294 | 0.160 |
Why?
|
Health Status | 2 | 2021 | 4034 | 0.160 |
Why?
|
Injections, Intramuscular | 4 | 2008 | 552 | 0.160 |
Why?
|
Ferrets | 4 | 2015 | 194 | 0.160 |
Why?
|
Cloning, Molecular | 13 | 2007 | 4320 | 0.160 |
Why?
|
Retroviruses, Simian | 1 | 1997 | 12 | 0.150 |
Why?
|
Europe | 9 | 2021 | 3339 | 0.150 |
Why?
|
Microscopy, Atomic Force | 1 | 2018 | 250 | 0.150 |
Why?
|
Genes, vpu | 1 | 1997 | 6 | 0.150 |
Why?
|
Scrapie | 4 | 1986 | 22 | 0.150 |
Why?
|
Genes, vpr | 1 | 1997 | 20 | 0.150 |
Why?
|
Immunologic Factors | 1 | 2007 | 1580 | 0.150 |
Why?
|
Africa | 6 | 2000 | 673 | 0.150 |
Why?
|
RNA | 4 | 2002 | 2749 | 0.150 |
Why?
|
Protein Conformation | 8 | 2018 | 4011 | 0.150 |
Why?
|
Biomimetic Materials | 1 | 2019 | 179 | 0.150 |
Why?
|
Developing Countries | 3 | 2006 | 2815 | 0.150 |
Why?
|
Cerebral Infarction | 1 | 2022 | 1011 | 0.150 |
Why?
|
Sensitivity and Specificity | 17 | 2011 | 14722 | 0.150 |
Why?
|
Middle Aged | 44 | 2021 | 213383 | 0.150 |
Why?
|
Primates | 2 | 1996 | 545 | 0.140 |
Why?
|
Brain | 12 | 2018 | 26385 | 0.140 |
Why?
|
Gene Products, rev | 3 | 1992 | 31 | 0.140 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2017 | 118 | 0.140 |
Why?
|
Virus Cultivation | 5 | 2012 | 92 | 0.140 |
Why?
|
Drug Resistance, Viral | 1 | 2001 | 820 | 0.140 |
Why?
|
Adolescent | 21 | 2021 | 85781 | 0.140 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 6 | 1989 | 906 | 0.140 |
Why?
|
Vero Cells | 3 | 2007 | 485 | 0.140 |
Why?
|
Protein Structure, Tertiary | 6 | 2009 | 3846 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 6 | 2006 | 1320 | 0.140 |
Why?
|
Dogs | 5 | 2019 | 3912 | 0.140 |
Why?
|
Leukocyte Count | 15 | 1994 | 1588 | 0.140 |
Why?
|
Muromonab-CD3 | 3 | 2001 | 96 | 0.140 |
Why?
|
Lymph Nodes | 9 | 2001 | 3474 | 0.140 |
Why?
|
Colon, Sigmoid | 1 | 1996 | 120 | 0.140 |
Why?
|
Hominidae | 2 | 1995 | 74 | 0.140 |
Why?
|
Gene Products, tat | 6 | 1992 | 120 | 0.140 |
Why?
|
Clinical Protocols | 2 | 2021 | 1462 | 0.140 |
Why?
|
Research Design | 3 | 2021 | 5987 | 0.130 |
Why?
|
Prospective Studies | 28 | 2021 | 53288 | 0.130 |
Why?
|
Gammaretrovirus | 1 | 1995 | 54 | 0.130 |
Why?
|
Attitude to Health | 1 | 2005 | 2052 | 0.130 |
Why?
|
Dependovirus | 1 | 2001 | 706 | 0.130 |
Why?
|
Drug Therapy, Combination | 16 | 2002 | 6489 | 0.130 |
Why?
|
Africa South of the Sahara | 4 | 2007 | 724 | 0.130 |
Why?
|
Prognosis | 20 | 2021 | 29063 | 0.130 |
Why?
|
History, 21st Century | 2 | 2014 | 1534 | 0.130 |
Why?
|
Aged | 17 | 2021 | 163280 | 0.130 |
Why?
|
Disease Models, Animal | 11 | 2021 | 18029 | 0.130 |
Why?
|
Age Factors | 5 | 2021 | 18370 | 0.130 |
Why?
|
Cytochrome b Group | 1 | 1995 | 60 | 0.130 |
Why?
|
Longitudinal Studies | 22 | 2021 | 13989 | 0.130 |
Why?
|
Endemic Diseases | 1 | 1996 | 182 | 0.130 |
Why?
|
Flow Cytometry | 11 | 2012 | 5974 | 0.130 |
Why?
|
Blood | 3 | 2000 | 598 | 0.130 |
Why?
|
Antigens, Bacterial | 3 | 2012 | 1171 | 0.130 |
Why?
|
Alanine Transaminase | 1 | 1998 | 592 | 0.130 |
Why?
|
Hemagglutinins | 2 | 2013 | 117 | 0.130 |
Why?
|
Palatine Tonsil | 5 | 1998 | 193 | 0.130 |
Why?
|
Young Adult | 10 | 2021 | 56430 | 0.130 |
Why?
|
Restriction Mapping | 7 | 1999 | 878 | 0.130 |
Why?
|
Membrane Fusion | 2 | 2014 | 273 | 0.130 |
Why?
|
Peptides, Cyclic | 1 | 2017 | 400 | 0.130 |
Why?
|
Fossils | 1 | 1995 | 76 | 0.130 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 6 | 1999 | 222 | 0.130 |
Why?
|
History, 20th Century | 3 | 2014 | 2740 | 0.130 |
Why?
|
Mathematics | 3 | 2006 | 728 | 0.130 |
Why?
|
Lymphocytes | 6 | 2011 | 2617 | 0.130 |
Why?
|
Adenovirus Infections, Human | 2 | 2006 | 71 | 0.130 |
Why?
|
Cells, Cultured | 23 | 2019 | 19229 | 0.130 |
Why?
|
Viral Matrix Proteins | 1 | 2015 | 186 | 0.120 |
Why?
|
Receptors, CXCR4 | 4 | 2004 | 726 | 0.120 |
Why?
|
Antigens, Surface | 6 | 2005 | 1663 | 0.120 |
Why?
|
HIV Seroprevalence | 2 | 2007 | 86 | 0.120 |
Why?
|
Jejunum | 1 | 1996 | 480 | 0.120 |
Why?
|
Orthomyxoviridae | 1 | 2015 | 156 | 0.120 |
Why?
|
Blood Pressure | 2 | 2021 | 8554 | 0.120 |
Why?
|
Drug Design | 3 | 2017 | 1076 | 0.120 |
Why?
|
Reproducibility of Results | 12 | 2021 | 19905 | 0.120 |
Why?
|
Phosphates | 2 | 2008 | 786 | 0.120 |
Why?
|
Protease Inhibitors | 1 | 1998 | 791 | 0.120 |
Why?
|
DNA Probes | 3 | 2001 | 560 | 0.120 |
Why?
|
Poliovirus Vaccine, Inactivated | 2 | 2012 | 24 | 0.120 |
Why?
|
Lectins, C-Type | 2 | 2009 | 588 | 0.120 |
Why?
|
Mutagenesis, Insertional | 4 | 2001 | 655 | 0.110 |
Why?
|
Swine | 4 | 2010 | 5917 | 0.110 |
Why?
|
Creatinine | 1 | 2019 | 1919 | 0.110 |
Why?
|
Morbidity | 1 | 2019 | 1769 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 4 | 2009 | 1838 | 0.110 |
Why?
|
Tetrazoles | 1 | 2019 | 835 | 0.110 |
Why?
|
Filoviridae | 1 | 2012 | 16 | 0.110 |
Why?
|
DNA | 4 | 2005 | 7301 | 0.110 |
Why?
|
alpha-Synuclein | 1 | 2019 | 723 | 0.110 |
Why?
|
Viral Structural Proteins | 2 | 2010 | 103 | 0.110 |
Why?
|
Culture Media, Serum-Free | 2 | 2012 | 158 | 0.110 |
Why?
|
Technology, Pharmaceutical | 1 | 2012 | 84 | 0.110 |
Why?
|
Virus Attachment | 2 | 2009 | 55 | 0.100 |
Why?
|
Monkey Diseases | 3 | 2001 | 77 | 0.100 |
Why?
|
Poliovirus | 1 | 2012 | 109 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3271 | 0.100 |
Why?
|
Disease Transmission, Infectious | 2 | 2001 | 547 | 0.100 |
Why?
|
Measles Vaccine | 1 | 2012 | 76 | 0.100 |
Why?
|
Receptors, Virus | 4 | 2009 | 648 | 0.100 |
Why?
|
Influenza A Virus, H7N7 Subtype | 1 | 2011 | 1 | 0.100 |
Why?
|
Risk Factors | 26 | 2024 | 72290 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 6 | 2009 | 1723 | 0.100 |
Why?
|
Antigen-Antibody Complex | 3 | 1990 | 517 | 0.100 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2010 | 281 | 0.100 |
Why?
|
Terminal Repeat Sequences | 3 | 2000 | 72 | 0.100 |
Why?
|
Paraparesis, Tropical Spastic | 1 | 1991 | 32 | 0.100 |
Why?
|
Virus Latency | 4 | 2003 | 358 | 0.100 |
Why?
|
HIV Protease Inhibitors | 5 | 2001 | 430 | 0.100 |
Why?
|
Marburgvirus | 2 | 2010 | 20 | 0.100 |
Why?
|
Leukemia, Myeloid | 2 | 2005 | 707 | 0.100 |
Why?
|
Gene Products, nef | 4 | 1992 | 110 | 0.100 |
Why?
|
Point Mutation | 3 | 2006 | 1623 | 0.100 |
Why?
|
Transcription, Genetic | 4 | 2002 | 7722 | 0.100 |
Why?
|
Antigen-Antibody Reactions | 3 | 2006 | 363 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2018 | 10943 | 0.100 |
Why?
|
Animals, Suckling | 2 | 2007 | 72 | 0.100 |
Why?
|
Mice, Inbred C57BL | 14 | 2009 | 21827 | 0.100 |
Why?
|
Receptors, HIV | 3 | 2001 | 162 | 0.100 |
Why?
|
Polyradiculoneuropathy | 2 | 1988 | 64 | 0.100 |
Why?
|
Mycobacterium bovis | 1 | 2011 | 150 | 0.100 |
Why?
|
Feces | 4 | 1998 | 1401 | 0.100 |
Why?
|
Bacterial Proteins | 3 | 2012 | 3848 | 0.100 |
Why?
|
Marburg Virus Disease | 1 | 2010 | 11 | 0.100 |
Why?
|
Models, Theoretical | 3 | 2019 | 3589 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 4 | 1998 | 2026 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2009 | 407 | 0.090 |
Why?
|
Selection, Genetic | 1 | 1995 | 914 | 0.090 |
Why?
|
Cerebral Hemorrhage | 1 | 2022 | 2647 | 0.090 |
Why?
|
Pichia | 1 | 2010 | 51 | 0.090 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 5 | 1991 | 127 | 0.090 |
Why?
|
Treatment Outcome | 13 | 2012 | 63114 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 1998 | 2382 | 0.090 |
Why?
|
Chemokines, CXC | 3 | 2002 | 422 | 0.090 |
Why?
|
Receptors, Leukocyte-Adhesion | 1 | 1990 | 53 | 0.090 |
Why?
|
Binding, Competitive | 5 | 1992 | 1157 | 0.090 |
Why?
|
Incidence | 11 | 2020 | 20947 | 0.090 |
Why?
|
Factor VIII | 3 | 1988 | 347 | 0.090 |
Why?
|
Immunity, Innate | 3 | 2021 | 2958 | 0.090 |
Why?
|
Immunoassay | 5 | 1999 | 752 | 0.090 |
Why?
|
Microglia | 1 | 2018 | 1266 | 0.090 |
Why?
|
Peptide Mapping | 5 | 2005 | 263 | 0.090 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4740 | 0.090 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2000 | 224 | 0.090 |
Why?
|
HIV Envelope Protein gp160 | 4 | 1995 | 99 | 0.090 |
Why?
|
Risk-Taking | 4 | 2005 | 986 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.090 |
Why?
|
Phosphorylation | 2 | 2018 | 8436 | 0.080 |
Why?
|
Sequence Analysis | 2 | 2002 | 256 | 0.080 |
Why?
|
Peptides | 9 | 2008 | 4409 | 0.080 |
Why?
|
Nobel Prize | 1 | 2009 | 49 | 0.080 |
Why?
|
AIDS Serodiagnosis | 2 | 1989 | 184 | 0.080 |
Why?
|
Lymphocyte Count | 5 | 2005 | 793 | 0.080 |
Why?
|
Squalene | 1 | 2008 | 32 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 2 | 2012 | 1832 | 0.080 |
Why?
|
Cause of Death | 1 | 2019 | 3584 | 0.080 |
Why?
|
Polysorbates | 1 | 2008 | 41 | 0.080 |
Why?
|
RNA, Messenger | 8 | 2003 | 13033 | 0.080 |
Why?
|
Double-Blind Method | 9 | 2012 | 12026 | 0.080 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1990 | 378 | 0.080 |
Why?
|
Hepatitis B virus | 2 | 2002 | 513 | 0.080 |
Why?
|
Surface Plasmon Resonance | 2 | 2006 | 274 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
Aluminum Hydroxide | 1 | 2008 | 58 | 0.080 |
Why?
|
Suramin | 1 | 1988 | 34 | 0.080 |
Why?
|
Ebolavirus | 3 | 2010 | 263 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 4751 | 0.080 |
Why?
|
Lymphocyte Subsets | 2 | 2008 | 315 | 0.080 |
Why?
|
Nucleic Acid Heteroduplexes | 3 | 2000 | 47 | 0.080 |
Why?
|
Smallpox | 1 | 2008 | 45 | 0.080 |
Why?
|
Deltaretrovirus Infections | 1 | 1987 | 26 | 0.080 |
Why?
|
Infant | 15 | 2011 | 35136 | 0.080 |
Why?
|
Lethal Dose 50 | 1 | 2007 | 77 | 0.080 |
Why?
|
Hot Temperature | 3 | 1988 | 1354 | 0.080 |
Why?
|
Propiolactone | 1 | 2007 | 5 | 0.080 |
Why?
|
Sporozoites | 1 | 2008 | 82 | 0.080 |
Why?
|
Oligonucleotides | 2 | 1991 | 572 | 0.080 |
Why?
|
Monocytes | 6 | 2009 | 2596 | 0.080 |
Why?
|
Pyridines | 2 | 2019 | 2825 | 0.080 |
Why?
|
Virus Inactivation | 1 | 2007 | 20 | 0.080 |
Why?
|
Smallpox Vaccine | 1 | 2008 | 80 | 0.080 |
Why?
|
Vitamin D-Binding Protein | 1 | 1988 | 129 | 0.080 |
Why?
|
Virulence | 4 | 1999 | 1333 | 0.080 |
Why?
|
Genetic Heterogeneity | 3 | 2001 | 733 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.080 |
Why?
|
Malaria | 2 | 2009 | 1239 | 0.080 |
Why?
|
Cytomegalovirus Infections | 2 | 2005 | 820 | 0.080 |
Why?
|
Interleukin-2 | 4 | 2008 | 1904 | 0.080 |
Why?
|
Liver Transplantation | 1 | 1998 | 2119 | 0.080 |
Why?
|
Macaca fascicularis | 5 | 2011 | 915 | 0.070 |
Why?
|
Oligonucleotide Probes | 4 | 1991 | 427 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2010 | 1791 | 0.070 |
Why?
|
Plasmapheresis | 1 | 1988 | 211 | 0.070 |
Why?
|
Follow-Up Studies | 21 | 2010 | 39050 | 0.070 |
Why?
|
Adenovirus E4 Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
Immunoglobulin A | 1 | 2010 | 992 | 0.070 |
Why?
|
Nandiniidae | 1 | 2006 | 1 | 0.070 |
Why?
|
Plasma | 1 | 2010 | 575 | 0.070 |
Why?
|
Paper | 1 | 2007 | 85 | 0.070 |
Why?
|
Drug Resistance | 3 | 1998 | 1609 | 0.070 |
Why?
|
Nucleoproteins | 2 | 2006 | 115 | 0.070 |
Why?
|
Genome | 1 | 1995 | 1808 | 0.070 |
Why?
|
Administration, Cutaneous | 1 | 2009 | 711 | 0.070 |
Why?
|
Carrier Proteins | 3 | 2009 | 5021 | 0.070 |
Why?
|
Treatment Failure | 3 | 2001 | 2618 | 0.070 |
Why?
|
Colony Count, Microbial | 1 | 2007 | 331 | 0.070 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2006 | 94 | 0.070 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1999 | 2214 | 0.070 |
Why?
|
Nucleic Acid Conformation | 4 | 1999 | 913 | 0.070 |
Why?
|
Visna-maedi virus | 1 | 1986 | 7 | 0.070 |
Why?
|
Infectious Anemia Virus, Equine | 1 | 1986 | 4 | 0.070 |
Why?
|
Gene Amplification | 2 | 1993 | 1063 | 0.070 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 3 | 1992 | 153 | 0.070 |
Why?
|
Child | 27 | 2011 | 77709 | 0.070 |
Why?
|
Vaccinia virus | 1 | 2008 | 349 | 0.070 |
Why?
|
Antigens, Neoplasm | 2 | 2005 | 1988 | 0.070 |
Why?
|
Theropithecus | 2 | 1995 | 2 | 0.070 |
Why?
|
Drug Carriers | 1 | 2011 | 693 | 0.070 |
Why?
|
Sheep | 4 | 2002 | 1437 | 0.070 |
Why?
|
Capsid | 2 | 1999 | 436 | 0.070 |
Why?
|
Biotechnology | 1 | 2008 | 281 | 0.070 |
Why?
|
Immunotherapy, Adoptive | 1 | 1995 | 1270 | 0.070 |
Why?
|
Republic of Belarus | 3 | 2006 | 38 | 0.070 |
Why?
|
Peptide Hydrolases | 1 | 1989 | 634 | 0.070 |
Why?
|
Prevalence | 8 | 2003 | 15226 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2002 | 5853 | 0.070 |
Why?
|
Plasmodium yoelii | 1 | 2006 | 39 | 0.070 |
Why?
|
Rwanda | 3 | 1997 | 703 | 0.070 |
Why?
|
Slow Virus Diseases | 1 | 1985 | 4 | 0.070 |
Why?
|
Blotting, Southern | 3 | 2000 | 803 | 0.070 |
Why?
|
Blood Coagulation Factors | 1 | 1988 | 355 | 0.070 |
Why?
|
Protein Sorting Signals | 1 | 2006 | 281 | 0.070 |
Why?
|
BCG Vaccine | 1 | 2008 | 369 | 0.070 |
Why?
|
Archaeology | 1 | 2005 | 37 | 0.070 |
Why?
|
Molecular Probes | 2 | 2005 | 316 | 0.070 |
Why?
|
Leukemia, Lymphoid | 1 | 1986 | 315 | 0.070 |
Why?
|
Genetic Complementation Test | 1 | 2006 | 562 | 0.070 |
Why?
|
Russia | 3 | 2007 | 408 | 0.070 |
Why?
|
Body Weight | 3 | 2015 | 4669 | 0.070 |
Why?
|
Survival Analysis | 4 | 2017 | 10252 | 0.070 |
Why?
|
Virus Integration | 3 | 1996 | 299 | 0.070 |
Why?
|
Hepatitis B Antigens | 1 | 1984 | 40 | 0.060 |
Why?
|
Thymus Gland | 2 | 1992 | 1267 | 0.060 |
Why?
|
Bacteriophages | 2 | 2005 | 356 | 0.060 |
Why?
|
Myeloid Cells | 2 | 2007 | 810 | 0.060 |
Why?
|
Cell Movement | 2 | 2008 | 5217 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3752 | 0.060 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 2013 | 1801 | 0.060 |
Why?
|
Substance-Related Disorders | 9 | 1994 | 4258 | 0.060 |
Why?
|
Heart Transplantation | 1 | 1998 | 3110 | 0.060 |
Why?
|
Blood Transfusion | 3 | 1986 | 1301 | 0.060 |
Why?
|
Immunity, Mucosal | 1 | 2008 | 490 | 0.060 |
Why?
|
Infant, Newborn | 11 | 2005 | 25625 | 0.060 |
Why?
|
Parkinson Disease | 1 | 2019 | 2775 | 0.060 |
Why?
|
Sexually Transmitted Diseases | 4 | 1998 | 624 | 0.060 |
Why?
|
Cytopathogenic Effect, Viral | 6 | 2004 | 156 | 0.060 |
Why?
|
GTP-Binding Proteins | 1 | 1989 | 970 | 0.060 |
Why?
|
Cytomegalovirus | 2 | 2007 | 732 | 0.060 |
Why?
|
Immunity, Active | 1 | 2004 | 60 | 0.060 |
Why?
|
Blood Donors | 3 | 2000 | 355 | 0.060 |
Why?
|
Sex Distribution | 2 | 2020 | 2297 | 0.060 |
Why?
|
Safety | 1 | 2009 | 1186 | 0.060 |
Why?
|
Africa, Southern | 1 | 2003 | 57 | 0.060 |
Why?
|
BK Virus | 2 | 1982 | 129 | 0.060 |
Why?
|
Lymphoid Tissue | 2 | 1998 | 455 | 0.060 |
Why?
|
Cell Line, Tumor | 7 | 2014 | 16689 | 0.060 |
Why?
|
Hepatitis Antibodies | 2 | 2002 | 73 | 0.060 |
Why?
|
Interferon-alpha | 3 | 2007 | 895 | 0.060 |
Why?
|
Glycosylation | 4 | 2009 | 1126 | 0.060 |
Why?
|
Cell Adhesion Molecules | 2 | 2009 | 1602 | 0.060 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 2 | 1996 | 39 | 0.060 |
Why?
|
Models, Animal | 2 | 2010 | 2171 | 0.060 |
Why?
|
Acute Disease | 9 | 2005 | 7149 | 0.060 |
Why?
|
Codon | 3 | 1997 | 611 | 0.060 |
Why?
|
Age Distribution | 2 | 2020 | 2902 | 0.060 |
Why?
|
Human Immunodeficiency Virus Proteins | 2 | 1996 | 65 | 0.060 |
Why?
|
Genetic Engineering | 2 | 2006 | 951 | 0.060 |
Why?
|
Skin | 4 | 2006 | 4364 | 0.060 |
Why?
|
Nevirapine | 3 | 1999 | 267 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 1999 | 4253 | 0.060 |
Why?
|
Orthotic Devices | 1 | 2004 | 128 | 0.060 |
Why?
|
Hepatitis B Antibodies | 2 | 1999 | 159 | 0.060 |
Why?
|
beta-Galactosidase | 4 | 2004 | 573 | 0.060 |
Why?
|
Quipazine | 2 | 1981 | 6 | 0.060 |
Why?
|
Trans-Activators | 2 | 1990 | 2924 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15540 | 0.050 |
Why?
|
Nucleic Acid Hybridization | 4 | 1990 | 1375 | 0.050 |
Why?
|
Ritonavir | 6 | 2001 | 322 | 0.050 |
Why?
|
Cross-Sectional Studies | 13 | 2003 | 25043 | 0.050 |
Why?
|
Protein Precursors | 3 | 1992 | 1154 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1993 | 708 | 0.050 |
Why?
|
Artificial Limbs | 1 | 2004 | 123 | 0.050 |
Why?
|
Genes, Regulator | 2 | 1997 | 378 | 0.050 |
Why?
|
Protein-Energy Malnutrition | 1 | 1983 | 187 | 0.050 |
Why?
|
Chemokine CXCL12 | 2 | 2002 | 464 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2014 | 712 | 0.050 |
Why?
|
Immunoblotting | 5 | 2013 | 1682 | 0.050 |
Why?
|
Tonsillitis | 1 | 1981 | 30 | 0.050 |
Why?
|
Egypt | 2 | 1999 | 100 | 0.050 |
Why?
|
Protein Binding | 4 | 2014 | 9386 | 0.050 |
Why?
|
Promoter Regions, Genetic | 3 | 2007 | 5867 | 0.050 |
Why?
|
5-Hydroxytryptophan | 1 | 1981 | 32 | 0.050 |
Why?
|
Drug Synergism | 1 | 2006 | 1792 | 0.050 |
Why?
|
Emigration and Immigration | 2 | 2000 | 404 | 0.050 |
Why?
|
Public Sector | 1 | 2003 | 265 | 0.050 |
Why?
|
Retrospective Studies | 14 | 2004 | 77449 | 0.050 |
Why?
|
Saquinavir | 1 | 2001 | 28 | 0.050 |
Why?
|
Chemokines | 3 | 2001 | 970 | 0.050 |
Why?
|
Hepatocytes | 1 | 2008 | 1211 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 2 | 2002 | 486 | 0.050 |
Why?
|
Oligopeptides | 4 | 1991 | 1189 | 0.050 |
Why?
|
HIV Seronegativity | 2 | 2001 | 211 | 0.050 |
Why?
|
Dideoxynucleosides | 2 | 1999 | 122 | 0.050 |
Why?
|
Blood-Brain Barrier | 2 | 1987 | 1017 | 0.050 |
Why?
|
Luciferases | 1 | 2003 | 733 | 0.050 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 294 | 0.050 |
Why?
|
Receptors, Serotonin | 2 | 1981 | 201 | 0.050 |
Why?
|
Hypergammaglobulinemia | 1 | 2001 | 74 | 0.050 |
Why?
|
Population Dynamics | 1 | 2003 | 302 | 0.050 |
Why?
|
Bird Diseases | 1 | 2001 | 19 | 0.050 |
Why?
|
Keratins | 1 | 2003 | 515 | 0.050 |
Why?
|
Calibration | 2 | 2001 | 816 | 0.050 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2001 | 66 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12720 | 0.050 |
Why?
|
Isomerism | 1 | 2001 | 201 | 0.050 |
Why?
|
Trinucleotide Repeats | 1 | 2002 | 261 | 0.050 |
Why?
|
Transgenes | 3 | 2012 | 1009 | 0.050 |
Why?
|
Child, Preschool | 15 | 2006 | 41006 | 0.050 |
Why?
|
HTLV-I Infections | 2 | 1991 | 101 | 0.050 |
Why?
|
Animals, Zoo | 1 | 2000 | 15 | 0.050 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1985 | 547 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 1983 | 324 | 0.050 |
Why?
|
Antigens, CD | 5 | 2005 | 4026 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8480 | 0.050 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 2 | 1991 | 28 | 0.050 |
Why?
|
Polyomavirus | 1 | 1981 | 248 | 0.050 |
Why?
|
Organizations, Nonprofit | 1 | 2001 | 104 | 0.050 |
Why?
|
Acidosis, Lactic | 1 | 2002 | 142 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 772 | 0.050 |
Why?
|
European Union | 1 | 2001 | 158 | 0.050 |
Why?
|
Gene Products, tax | 3 | 1994 | 51 | 0.050 |
Why?
|
Animal Husbandry | 1 | 2000 | 66 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5751 | 0.050 |
Why?
|
Untranslated Regions | 1 | 2000 | 31 | 0.050 |
Why?
|
Gammaherpesvirinae | 1 | 2000 | 27 | 0.050 |
Why?
|
Vaccines, Attenuated | 2 | 2012 | 342 | 0.050 |
Why?
|
Galectins | 1 | 2003 | 268 | 0.050 |
Why?
|
Didanosine | 2 | 2004 | 153 | 0.050 |
Why?
|
Mitochondrial Diseases | 1 | 2004 | 320 | 0.050 |
Why?
|
Virology | 3 | 1997 | 77 | 0.040 |
Why?
|
Immunohistochemistry | 8 | 2003 | 11366 | 0.040 |
Why?
|
Immunophenotyping | 3 | 2007 | 1880 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2019 | 4204 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2009 | 2866 | 0.040 |
Why?
|
RNA Probes | 2 | 1989 | 113 | 0.040 |
Why?
|
Protein Structure, Secondary | 2 | 2015 | 1246 | 0.040 |
Why?
|
Hydrogen Bonding | 2 | 2009 | 293 | 0.040 |
Why?
|
Tissue Donors | 1 | 2008 | 2240 | 0.040 |
Why?
|
Gene Expression | 3 | 2007 | 7799 | 0.040 |
Why?
|
Spumavirus | 1 | 1998 | 16 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 3 | 2005 | 323 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 1982 | 452 | 0.040 |
Why?
|
Caseins | 1 | 1999 | 104 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 5 | 1989 | 2505 | 0.040 |
Why?
|
Hyperplasia | 2 | 1995 | 1185 | 0.040 |
Why?
|
Seasons | 2 | 2015 | 1493 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2001 | 853 | 0.040 |
Why?
|
Liver | 4 | 2009 | 7474 | 0.040 |
Why?
|
Automation | 1 | 2001 | 584 | 0.040 |
Why?
|
HeLa Cells | 6 | 2007 | 3128 | 0.040 |
Why?
|
Receptors, Dopamine D2 | 1 | 2000 | 475 | 0.040 |
Why?
|
Hepatitis E | 1 | 1999 | 76 | 0.040 |
Why?
|
Endopeptidases | 1 | 2001 | 772 | 0.040 |
Why?
|
Predictive Value of Tests | 5 | 2003 | 15076 | 0.040 |
Why?
|
Cytokines | 5 | 2012 | 7322 | 0.040 |
Why?
|
Infant, Newborn, Diseases | 1 | 1983 | 582 | 0.040 |
Why?
|
Receptors, Cytokine | 1 | 1998 | 261 | 0.040 |
Why?
|
Cattle | 2 | 2001 | 3922 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 1988 | 4328 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2002 | 685 | 0.040 |
Why?
|
Sequence Deletion | 3 | 1998 | 1526 | 0.040 |
Why?
|
Liberia | 4 | 1986 | 167 | 0.040 |
Why?
|
Acyclovir | 3 | 1989 | 272 | 0.040 |
Why?
|
Methylation | 2 | 1990 | 1106 | 0.040 |
Why?
|
India | 1 | 2003 | 2197 | 0.040 |
Why?
|
CHO Cells | 2 | 2004 | 1406 | 0.040 |
Why?
|
Health Resources | 1 | 2003 | 911 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2021 | 541 | 0.040 |
Why?
|
Directed Molecular Evolution | 1 | 1998 | 160 | 0.040 |
Why?
|
Complementarity Determining Regions | 1 | 2017 | 149 | 0.040 |
Why?
|
Tanzania | 2 | 1993 | 1346 | 0.040 |
Why?
|
Models, Immunological | 1 | 1999 | 527 | 0.040 |
Why?
|
Mesencephalon | 1 | 2019 | 329 | 0.040 |
Why?
|
Measles | 2 | 2012 | 168 | 0.040 |
Why?
|
Mosaicism | 1 | 2000 | 441 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2006 | 2564 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2003 | 1423 | 0.040 |
Why?
|
False Positive Reactions | 2 | 1997 | 981 | 0.040 |
Why?
|
Quinolines | 1 | 1981 | 732 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 1996 | 131 | 0.030 |
Why?
|
Interferon Type I | 2 | 1990 | 542 | 0.030 |
Why?
|
Survivors | 4 | 1999 | 2291 | 0.030 |
Why?
|
Cell Culture Techniques | 2 | 2009 | 1678 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2000 | 595 | 0.030 |
Why?
|
Cercocebus | 1 | 1995 | 1 | 0.030 |
Why?
|
Kuru | 2 | 1985 | 4 | 0.030 |
Why?
|
Time | 1 | 2017 | 542 | 0.030 |
Why?
|
Mummies | 1 | 1995 | 11 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2019 | 427 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 1998 | 669 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1994 | 442 | 0.030 |
Why?
|
Macrophages | 3 | 2006 | 5655 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Tropism | 2 | 2004 | 41 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 840 | 0.030 |
Why?
|
Membrane Proteins | 3 | 2005 | 7880 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3036 | 0.030 |
Why?
|
Mice, Inbred C3H | 2 | 2007 | 964 | 0.030 |
Why?
|
Life Tables | 2 | 1997 | 370 | 0.030 |
Why?
|
Lung | 3 | 2010 | 9856 | 0.030 |
Why?
|
Injections | 2 | 1992 | 840 | 0.030 |
Why?
|
Epilepsy | 3 | 1986 | 3310 | 0.030 |
Why?
|
Tyrosine | 1 | 1999 | 1461 | 0.030 |
Why?
|
Receptors, IgG | 1 | 2017 | 582 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 1982 | 961 | 0.030 |
Why?
|
Agglutination Tests | 3 | 1988 | 41 | 0.030 |
Why?
|
Needle Sharing | 1 | 1993 | 24 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2000 | 570 | 0.030 |
Why?
|
Breast Feeding | 2 | 2005 | 1338 | 0.030 |
Why?
|
Risk | 5 | 1987 | 9687 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2006 | 11483 | 0.030 |
Why?
|
Toxoplasmosis, Congenital | 1 | 1993 | 8 | 0.030 |
Why?
|
Skin Neoplasms | 2 | 2003 | 5686 | 0.030 |
Why?
|
Virus Assembly | 2 | 2004 | 144 | 0.030 |
Why?
|
Chromatography, Gel | 1 | 2013 | 668 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15165 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2013 | 2645 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2000 | 1222 | 0.030 |
Why?
|
Erythema Infectiosum | 1 | 1993 | 15 | 0.030 |
Why?
|
HTLV-I Antibodies | 2 | 1991 | 35 | 0.030 |
Why?
|
Pregnancy | 8 | 2001 | 29144 | 0.030 |
Why?
|
ISCOMs | 1 | 2012 | 2 | 0.030 |
Why?
|
Mutagenesis | 1 | 1997 | 1266 | 0.030 |
Why?
|
Hepatitis B Surface Antigens | 2 | 1984 | 305 | 0.030 |
Why?
|
Immunologic Techniques | 3 | 1988 | 218 | 0.030 |
Why?
|
Stromal Cells | 1 | 1998 | 1355 | 0.030 |
Why?
|
Research | 1 | 2001 | 1999 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1997 | 632 | 0.030 |
Why?
|
Microscopy, Fluorescence | 3 | 2014 | 2699 | 0.030 |
Why?
|
Gene Dosage | 1 | 1997 | 1252 | 0.030 |
Why?
|
Molecular Conformation | 1 | 2013 | 563 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2009 | 2715 | 0.030 |
Why?
|
Leukemia Virus, Bovine | 1 | 1991 | 9 | 0.030 |
Why?
|
Cerebrospinal Fluid | 2 | 1993 | 534 | 0.030 |
Why?
|
Immune System | 1 | 1998 | 805 | 0.030 |
Why?
|
Evaluation Studies as Topic | 4 | 1998 | 1681 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 1993 | 573 | 0.030 |
Why?
|
Forecasting | 1 | 2001 | 2951 | 0.030 |
Why?
|
Germinal Center | 1 | 1995 | 377 | 0.030 |
Why?
|
Transcription Factors | 2 | 1989 | 12208 | 0.030 |
Why?
|
HTLV-II Infections | 1 | 1991 | 4 | 0.030 |
Why?
|
Transaminases | 1 | 2012 | 199 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 964 | 0.030 |
Why?
|
Zalcitabine | 2 | 2004 | 42 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2009 | 1801 | 0.030 |
Why?
|
Glioma | 1 | 2006 | 3401 | 0.030 |
Why?
|
Genes | 2 | 2002 | 1893 | 0.020 |
Why?
|
Immunotherapy | 2 | 2006 | 4445 | 0.020 |
Why?
|
Proteomics | 1 | 2005 | 3638 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 1990 | 2988 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2005 | 4149 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2012 | 393 | 0.020 |
Why?
|
Deltaretrovirus Antibodies | 2 | 1987 | 9 | 0.020 |
Why?
|
Models, Genetic | 1 | 2001 | 3494 | 0.020 |
Why?
|
Leukemia, T-Cell | 1 | 1991 | 104 | 0.020 |
Why?
|
CD4-CD8 Ratio | 2 | 2001 | 112 | 0.020 |
Why?
|
Human Experimentation | 1 | 2012 | 127 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3913 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3508 | 0.020 |
Why?
|
United States | 5 | 2020 | 69872 | 0.020 |
Why?
|
USSR | 2 | 2000 | 21 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 1992 | 252 | 0.020 |
Why?
|
Complement C3 | 1 | 1993 | 461 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3647 | 0.020 |
Why?
|
Cell Division | 3 | 1999 | 4568 | 0.020 |
Why?
|
Telomere | 1 | 1996 | 910 | 0.020 |
Why?
|
Anticodon | 1 | 1990 | 25 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2015 | 970 | 0.020 |
Why?
|
Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
Clone Cells | 3 | 2005 | 1692 | 0.020 |
Why?
|
Hepatitis, Viral, Human | 1 | 1990 | 138 | 0.020 |
Why?
|
Area Under Curve | 1 | 2014 | 1654 | 0.020 |
Why?
|
Models, Structural | 1 | 1990 | 361 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4286 | 0.020 |
Why?
|
Base Composition | 1 | 1990 | 293 | 0.020 |
Why?
|
Africa, Eastern | 1 | 1989 | 71 | 0.020 |
Why?
|
Lentivirus | 1 | 1993 | 501 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2003 | 9438 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1995 | 3129 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1993 | 795 | 0.020 |
Why?
|
Gene Frequency | 1 | 1996 | 3588 | 0.020 |
Why?
|
Africa, Western | 1 | 1989 | 154 | 0.020 |
Why?
|
Blotting, Western | 4 | 1991 | 5179 | 0.020 |
Why?
|
Glutamine | 1 | 1992 | 578 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2014 | 1254 | 0.020 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2009 | 87 | 0.020 |
Why?
|
Drug Combinations | 2 | 2005 | 1959 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2622 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1990 | 462 | 0.020 |
Why?
|
Cell Membrane | 2 | 2004 | 3748 | 0.020 |
Why?
|
Neopterin | 1 | 1989 | 56 | 0.020 |
Why?
|
Organophosphorus Compounds | 1 | 1990 | 215 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2011 | 579 | 0.020 |
Why?
|
Precipitin Tests | 1 | 1990 | 829 | 0.020 |
Why?
|
Social Behavior | 1 | 1995 | 1127 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 3 | 1994 | 821 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1988 | 222 | 0.020 |
Why?
|
Arginine | 1 | 1992 | 944 | 0.020 |
Why?
|
Tetanus Toxoid | 3 | 1999 | 193 | 0.020 |
Why?
|
Serine | 1 | 1992 | 826 | 0.020 |
Why?
|
Ectromelia virus | 1 | 2008 | 5 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 1988 | 181 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2006 | 8863 | 0.020 |
Why?
|
Microscopy, Immunoelectron | 3 | 1993 | 319 | 0.020 |
Why?
|
Hemolysin Proteins | 1 | 2008 | 113 | 0.020 |
Why?
|
Host-Parasite Interactions | 1 | 1991 | 295 | 0.020 |
Why?
|
Immunochemistry | 1 | 1988 | 124 | 0.020 |
Why?
|
Lactoferrin | 1 | 2009 | 97 | 0.020 |
Why?
|
Thermodynamics | 1 | 1990 | 596 | 0.020 |
Why?
|
Africa, Central | 1 | 1988 | 7 | 0.020 |
Why?
|
RNA 3' Polyadenylation Signals | 1 | 2007 | 10 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2011 | 4420 | 0.020 |
Why?
|
Indinavir | 2 | 1998 | 74 | 0.020 |
Why?
|
Regression Analysis | 4 | 2005 | 6459 | 0.020 |
Why?
|
Frozen Sections | 1 | 1988 | 155 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 1989 | 484 | 0.020 |
Why?
|
Gene Transfer Techniques | 2 | 2003 | 1224 | 0.020 |
Why?
|
Aerosols | 1 | 2010 | 625 | 0.020 |
Why?
|
Reference Values | 3 | 2003 | 4982 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 1990 | 433 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1994 | 1783 | 0.020 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 1988 | 222 | 0.020 |
Why?
|
Clinical Trials as Topic | 3 | 2005 | 7913 | 0.020 |
Why?
|
Endosomes | 1 | 2010 | 520 | 0.020 |
Why?
|
Syphilis | 3 | 2001 | 227 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5319 | 0.020 |
Why?
|
Mitochondria | 1 | 2000 | 3520 | 0.020 |
Why?
|
Polysaccharides | 1 | 1994 | 1053 | 0.020 |
Why?
|
Saponins | 1 | 2007 | 50 | 0.020 |
Why?
|
Fever | 2 | 1999 | 1616 | 0.020 |
Why?
|
Random Allocation | 2 | 1988 | 2429 | 0.020 |
Why?
|
Arboviruses | 1 | 1986 | 12 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2007 | 253 | 0.020 |
Why?
|
Hemorrhagic Fevers, Viral | 1 | 1986 | 24 | 0.020 |
Why?
|
Iatrogenic Disease | 1 | 1990 | 547 | 0.020 |
Why?
|
Silicon Dioxide | 2 | 1999 | 213 | 0.020 |
Why?
|
Arbovirus Infections | 1 | 1986 | 20 | 0.020 |
Why?
|
Injections, Intradermal | 1 | 2006 | 117 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2007 | 428 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1988 | 307 | 0.020 |
Why?
|
Nervous System Diseases | 2 | 1989 | 1622 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3527 | 0.020 |
Why?
|
Liver Diseases, Parasitic | 1 | 2006 | 10 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
Blood Protein Electrophoresis | 1 | 1986 | 73 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2002 | 8428 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 1987 | 919 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1999 | 2245 | 0.020 |
Why?
|
Organ Specificity | 2 | 2006 | 2008 | 0.020 |
Why?
|
Filtration | 1 | 2007 | 234 | 0.020 |
Why?
|
Placebos | 1 | 2010 | 1676 | 0.020 |
Why?
|
Embalming | 1 | 2005 | 13 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2006 | 448 | 0.020 |
Why?
|
SSPE Virus | 1 | 1985 | 3 | 0.020 |
Why?
|
Cryoelectron Microscopy | 1 | 2009 | 571 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1539 | 0.020 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 1989 | 370 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 319 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2014 | 1477 | 0.020 |
Why?
|
Exanthema | 1 | 1990 | 501 | 0.020 |
Why?
|
Receptors, Thrombopoietin | 1 | 2007 | 157 | 0.020 |
Why?
|
DNA, Recombinant | 1 | 2006 | 476 | 0.020 |
Why?
|
Genetic Code | 1 | 1986 | 154 | 0.020 |
Why?
|
Chimera | 2 | 2001 | 485 | 0.020 |
Why?
|
Autopsy | 1 | 1989 | 1020 | 0.020 |
Why?
|
Immunoglobulin Fragments | 1 | 2005 | 84 | 0.020 |
Why?
|
Hepatitis delta Antigens | 1 | 1984 | 7 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 2007 | 246 | 0.020 |
Why?
|
Genes, Reporter | 2 | 2003 | 1547 | 0.020 |
Why?
|
RNA Viruses | 1 | 1986 | 124 | 0.020 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2006 | 177 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 627 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2006 | 387 | 0.020 |
Why?
|
History, Ancient | 1 | 2005 | 212 | 0.020 |
Why?
|
Activated-Leukocyte Cell Adhesion Molecule | 1 | 2005 | 22 | 0.020 |
Why?
|
Merozoite Surface Protein 1 | 1 | 2005 | 38 | 0.020 |
Why?
|
Chromosome Aberrations | 2 | 1982 | 1813 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1988 | 675 | 0.020 |
Why?
|
Cameroon | 2 | 1998 | 71 | 0.020 |
Why?
|
Molecular Structure | 1 | 1989 | 1899 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 1988 | 389 | 0.020 |
Why?
|
Helper Viruses | 1 | 2004 | 58 | 0.020 |
Why?
|
Humidity | 1 | 2005 | 197 | 0.020 |
Why?
|
South Africa | 1 | 2010 | 1731 | 0.020 |
Why?
|
HLA-B7 Antigen | 1 | 2004 | 48 | 0.020 |
Why?
|
Diagnosis, Differential | 4 | 1990 | 12959 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 1999 | 1950 | 0.020 |
Why?
|
Serial Passage | 1 | 2004 | 23 | 0.020 |
Why?
|
Epithelium | 1 | 1989 | 1679 | 0.020 |
Why?
|
Mothers | 1 | 1995 | 2165 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 1985 | 269 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 2557 | 0.010 |
Why?
|
Adenovirus E1B Proteins | 1 | 2003 | 15 | 0.010 |
Why?
|
Iridoviridae | 1 | 1983 | 9 | 0.010 |
Why?
|
African Swine Fever Virus | 1 | 1983 | 6 | 0.010 |
Why?
|
HLA-A Antigens | 1 | 2004 | 231 | 0.010 |
Why?
|
Perinatal Care | 1 | 2005 | 227 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2007 | 1341 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1988 | 518 | 0.010 |
Why?
|
Plasmids | 2 | 2003 | 2307 | 0.010 |
Why?
|
Albumins | 1 | 1986 | 569 | 0.010 |
Why?
|
Trifluridine | 1 | 1983 | 29 | 0.010 |
Why?
|
Idoxuridine | 1 | 1983 | 123 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 1988 | 1677 | 0.010 |
Why?
|
Heterozygote | 3 | 1998 | 2804 | 0.010 |
Why?
|
Serum Albumin | 1 | 1986 | 676 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1989 | 3508 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2008 | 931 | 0.010 |
Why?
|
Population Surveillance | 2 | 2005 | 2616 | 0.010 |
Why?
|
Paresis | 1 | 2004 | 179 | 0.010 |
Why?
|
Muscle Neoplasms | 1 | 2004 | 139 | 0.010 |
Why?
|
Myoblasts | 1 | 2004 | 238 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 1983 | 322 | 0.010 |
Why?
|
Academies and Institutes | 1 | 2005 | 317 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 1988 | 1364 | 0.010 |
Why?
|
Autoantibodies | 2 | 1988 | 2035 | 0.010 |
Why?
|
Cell Polarity | 1 | 2006 | 645 | 0.010 |
Why?
|
Poly A | 1 | 2002 | 185 | 0.010 |
Why?
|
Geography | 1 | 1984 | 669 | 0.010 |
Why?
|
Protein Subunits | 1 | 2006 | 959 | 0.010 |
Why?
|
Cell Survival | 2 | 2007 | 5882 | 0.010 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2002 | 154 | 0.010 |
Why?
|
COS Cells | 1 | 2004 | 1161 | 0.010 |
Why?
|
Inbreeding | 1 | 2001 | 49 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 1 | 2001 | 313 | 0.010 |
Why?
|
Vidarabine | 1 | 1983 | 345 | 0.010 |
Why?
|
Haiti | 1 | 1983 | 553 | 0.010 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2004 | 256 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2004 | 844 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2004 | 563 | 0.010 |
Why?
|
Calcium | 1 | 1994 | 5756 | 0.010 |
Why?
|
Quality Control | 1 | 2003 | 841 | 0.010 |
Why?
|
DNA Replication | 2 | 2002 | 1399 | 0.010 |
Why?
|
Genes, Neoplasm | 1 | 2002 | 376 | 0.010 |
Why?
|
Synovial Membrane | 1 | 2003 | 507 | 0.010 |
Why?
|
Belgium | 1 | 2000 | 103 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 686 | 0.010 |
Why?
|
Electrochemistry | 1 | 2000 | 145 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 1988 | 12072 | 0.010 |
Why?
|
Romania | 1 | 2000 | 96 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 2327 | 0.010 |
Why?
|
Urine | 1 | 1981 | 370 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1985 | 1185 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2005 | 1375 | 0.010 |
Why?
|
Contraceptive Devices, Male | 2 | 1989 | 13 | 0.010 |
Why?
|
Chemokine CXCL10 | 1 | 2000 | 304 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2004 | 6365 | 0.010 |
Why?
|
Gene Library | 1 | 2002 | 1074 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2002 | 769 | 0.010 |
Why?
|
Interleukins | 1 | 2004 | 791 | 0.010 |
Why?
|
Thiocyanates | 1 | 1999 | 70 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2003 | 934 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4217 | 0.010 |
Why?
|
Lymphocyte Depletion | 1 | 2001 | 608 | 0.010 |
Why?
|
Government Programs | 1 | 2001 | 275 | 0.010 |
Why?
|
Thrombin | 1 | 2001 | 598 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 1993 | 20129 | 0.010 |
Why?
|
Isoleucine | 1 | 1998 | 112 | 0.010 |
Why?
|
Jews | 1 | 1981 | 385 | 0.010 |
Why?
|
Temperature | 1 | 2005 | 2206 | 0.010 |
Why?
|
Leg | 1 | 2004 | 1116 | 0.010 |
Why?
|
Immune Tolerance | 1 | 1988 | 2258 | 0.010 |
Why?
|
Chronic Disease | 2 | 2000 | 9146 | 0.010 |
Why?
|
Lymphoma | 1 | 1988 | 1877 | 0.010 |
Why?
|
Gait | 1 | 2004 | 793 | 0.010 |
Why?
|
Guanidines | 1 | 1999 | 193 | 0.010 |
Why?
|
Bleomycin | 1 | 1999 | 512 | 0.010 |
Why?
|
Apoptosis | 1 | 1994 | 9727 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2002 | 749 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2000 | 617 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 1998 | 212 | 0.010 |
Why?
|
Diarrhea | 1 | 1985 | 1348 | 0.010 |
Why?
|
Chemokines, CC | 1 | 1998 | 291 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2004 | 1338 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2203 | 0.010 |
Why?
|
Aneuploidy | 1 | 1981 | 530 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2004 | 1578 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1989 | 2133 | 0.010 |
Why?
|
Vincristine | 1 | 1999 | 1039 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2005 | 1226 | 0.010 |
Why?
|
HLA Antigens | 2 | 1993 | 1381 | 0.010 |
Why?
|
Valine | 1 | 1998 | 413 | 0.010 |
Why?
|
Genetic Linkage | 1 | 1982 | 2421 | 0.010 |
Why?
|
Gonorrhea | 1 | 2001 | 335 | 0.010 |
Why?
|
Radiography | 1 | 1988 | 7023 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 1996 | 288 | 0.010 |
Why?
|
Serotonin | 1 | 1981 | 1017 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 2 | 1990 | 249 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1999 | 13695 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10481 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2088 | 0.010 |
Why?
|
Occupational Health | 1 | 2002 | 809 | 0.010 |
Why?
|
Universities | 1 | 2001 | 956 | 0.010 |
Why?
|
Lithuania | 1 | 1995 | 13 | 0.010 |
Why?
|
Equipment Design | 1 | 2004 | 3582 | 0.010 |
Why?
|
Knee Joint | 1 | 2004 | 1680 | 0.010 |
Why?
|
HTLV-I Antigens | 1 | 1994 | 7 | 0.010 |
Why?
|
Genes, pX | 1 | 1994 | 7 | 0.010 |
Why?
|
RNA, Double-Stranded | 1 | 1996 | 290 | 0.010 |
Why?
|
Ionomycin | 1 | 1994 | 109 | 0.010 |
Why?
|
Sexual Partners | 2 | 1989 | 730 | 0.010 |
Why?
|
Antigen-Presenting Cells | 2 | 1989 | 973 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1994 | 76 | 0.010 |
Why?
|
Egtazic Acid | 1 | 1994 | 173 | 0.010 |
Why?
|
DNA, Single-Stranded | 1 | 1996 | 354 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1994 | 475 | 0.010 |
Why?
|
Rats | 2 | 1988 | 24260 | 0.010 |
Why?
|
Thailand | 1 | 1994 | 296 | 0.010 |
Why?
|
Lac Operon | 1 | 1993 | 238 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 1993 | 35421 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1917 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 1998 | 12354 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3282 | 0.010 |
Why?
|
Adhesiveness | 1 | 1993 | 53 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9734 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2000 | 1676 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 1993 | 55 | 0.010 |
Why?
|
Homozygote | 1 | 1998 | 1785 | 0.010 |
Why?
|
Parvovirus B19, Human | 1 | 1993 | 38 | 0.010 |
Why?
|
Pedigree | 1 | 1981 | 4644 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1994 | 898 | 0.010 |
Why?
|
Confidence Intervals | 1 | 1998 | 2971 | 0.010 |
Why?
|
Case-Control Studies | 3 | 1997 | 21746 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1993 | 719 | 0.010 |
Why?
|
Doxorubicin | 1 | 1999 | 2234 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2002 | 3200 | 0.010 |
Why?
|
Sp1 Transcription Factor | 1 | 1992 | 144 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1987 | 3079 | 0.010 |
Why?
|
DNA, Circular | 1 | 1992 | 97 | 0.010 |
Why?
|
HTLV-II Antibodies | 1 | 1991 | 3 | 0.010 |
Why?
|
Toxoplasma | 1 | 1993 | 150 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2001 | 2494 | 0.010 |
Why?
|
Telomerase | 1 | 1996 | 730 | 0.010 |
Why?
|
Cyclosporine | 1 | 1994 | 786 | 0.010 |
Why?
|
Antibody-Producing Cells | 1 | 1991 | 143 | 0.010 |
Why?
|
Biopsy | 1 | 2003 | 6756 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2004 | 3479 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 1996 | 1465 | 0.010 |
Why?
|
Motor Activity | 1 | 1981 | 2714 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2002 | 3023 | 0.010 |
Why?
|
Cell Death | 1 | 1996 | 1706 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1993 | 456 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 1997 | 12245 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1997 | 3144 | 0.010 |
Why?
|
Diphtheria Toxoid | 1 | 1990 | 28 | 0.010 |
Why?
|
Brazil | 1 | 1994 | 1270 | 0.010 |
Why?
|
Heroin | 1 | 1990 | 117 | 0.010 |
Why?
|
Uganda | 1 | 1994 | 1243 | 0.010 |
Why?
|
Infectious Mononucleosis | 1 | 1990 | 131 | 0.010 |
Why?
|
Anemia | 1 | 1999 | 1506 | 0.010 |
Why?
|
Protein Kinase C | 1 | 1994 | 1227 | 0.010 |
Why?
|
Bisexuality | 1 | 1991 | 270 | 0.010 |
Why?
|
Pacific Islands | 1 | 1988 | 50 | 0.010 |
Why?
|
Homeostasis | 1 | 2000 | 3340 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 9959 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1993 | 1155 | 0.010 |
Why?
|
Demography | 1 | 1993 | 1656 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 1990 | 565 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1998 | 2716 | 0.000 |
Why?
|
Lymphocyte Cooperation | 1 | 1987 | 112 | 0.000 |
Why?
|
Pilot Projects | 1 | 2001 | 8324 | 0.000 |
Why?
|
Herpes Zoster | 1 | 1990 | 264 | 0.000 |
Why?
|
Neoplasms | 1 | 1996 | 21683 | 0.000 |
Why?
|
Mitogens | 1 | 1987 | 232 | 0.000 |
Why?
|
Platelet Count | 1 | 1990 | 781 | 0.000 |
Why?
|
Bunyaviridae | 1 | 1986 | 1 | 0.000 |
Why?
|
Togaviridae Infections | 1 | 1986 | 1 | 0.000 |
Why?
|
Bunyaviridae Infections | 1 | 1986 | 2 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6314 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1987 | 179 | 0.000 |
Why?
|
Rift Valley fever virus | 1 | 1986 | 5 | 0.000 |
Why?
|
Alphavirus | 1 | 1986 | 9 | 0.000 |
Why?
|
Hemorrhagic Fever Virus, Crimean-Congo | 1 | 1986 | 6 | 0.000 |
Why?
|
Flavivirus | 1 | 1986 | 20 | 0.000 |
Why?
|
Solubility | 1 | 1988 | 1085 | 0.000 |
Why?
|
Trachea | 1 | 1992 | 1076 | 0.000 |
Why?
|
Nitrites | 1 | 1986 | 160 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1988 | 647 | 0.000 |
Why?
|
Lassa virus | 1 | 1986 | 97 | 0.000 |
Why?
|
Pancreas | 1 | 1992 | 1686 | 0.000 |
Why?
|
Australia | 1 | 1988 | 1170 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1990 | 1041 | 0.000 |
Why?
|
Cell Separation | 1 | 1990 | 1751 | 0.000 |
Why?
|
NF-kappa B | 1 | 1992 | 2499 | 0.000 |
Why?
|
Encephalitis | 1 | 1987 | 423 | 0.000 |
Why?
|
Intestines | 1 | 1992 | 1924 | 0.000 |
Why?
|
Rabbits | 1 | 1990 | 4894 | 0.000 |
Why?
|
Iodine Radioisotopes | 1 | 1987 | 1032 | 0.000 |
Why?
|
Molecular Weight | 1 | 1985 | 2255 | 0.000 |
Why?
|
Marijuana Abuse | 1 | 1986 | 403 | 0.000 |
Why?
|
Educational Status | 1 | 1990 | 2540 | 0.000 |
Why?
|
Antigens | 1 | 1987 | 1466 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1990 | 4186 | 0.000 |
Why?
|
Escherichia coli | 1 | 1993 | 4217 | 0.000 |
Why?
|
Chromosome Banding | 1 | 1981 | 278 | 0.000 |
Why?
|
Sex Chromosome Aberrations | 1 | 1981 | 114 | 0.000 |
Why?
|
Urban Population | 1 | 1989 | 2021 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1997 | 8949 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1990 | 2576 | 0.000 |
Why?
|
Data Collection | 1 | 1989 | 3341 | 0.000 |
Why?
|
Karyotyping | 1 | 1981 | 1243 | 0.000 |
Why?
|
Ataxia | 1 | 1981 | 304 | 0.000 |
Why?
|
Rural Population | 1 | 1989 | 2210 | 0.000 |
Why?
|
Computer Simulation | 1 | 1991 | 6196 | 0.000 |
Why?
|
Developmental Disabilities | 1 | 1986 | 1456 | 0.000 |
Why?
|
Behavior, Animal | 1 | 1981 | 1881 | 0.000 |
Why?
|
Sex Factors | 1 | 1986 | 10397 | 0.000 |
Why?
|
Drug Hypersensitivity | 1 | 1981 | 884 | 0.000 |
Why?
|